Actinogen Medical Limited 

$0.000800
6
+$0.00+0% Thursday 13:30

Statistics

Day High
0.0008
Day Low
0.0008
52W High
0.04
52W Low
0.0008
Volume
-
Avg. Volume
-
Mkt Cap
2.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-19.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATGGF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Actinogen Medical Limited is an Australian biotechnology firm specializing in the creation of treatments for neurological and neuropsychiatric conditions linked to abnormal brain cortisol levels. Their primary therapeutic candidate, Xanamem, functions as an inhibitor of the 11ß-HSD1 enzyme. Currently in Phase 2 clinical trials, Xanamem has shown the ability to engage its intended target within the central nervous system. Its development focuses on addressing Alzheimer's disease, cognitive impairment associated with depression, and the anxiety, sleep, and behavioral challenges seen in fragile X syndrome. Founded in 1999, the company, based in Sydney, Australia, operated as Actinogen Limited until its name change to Actinogen Medical Limited in November 2015.
Show more...
CEO
Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.
Employees
6
Country
United States
ISIN
AU000000ACW3

Listings

0 Comments

Share your thoughts

FAQ

What is Actinogen Medical Limited stock price today?
The current price of ATGGF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Actinogen Medical Limited stock price performance more closely on the chart.
What is Actinogen Medical Limited stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Actinogen Medical Limited stocks are traded under the ticker ATGGF.
Is Actinogen Medical Limited stock price growing?
ATGGF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Actinogen Medical Limited has showed a -92% decrease.
What is Actinogen Medical Limited market cap?
Today Actinogen Medical Limited has the market capitalization of 2.55M
When is the next Actinogen Medical Limited earnings date?
Actinogen Medical Limited is going to release the next earnings report on August 31, 2026.
What were Actinogen Medical Limited earnings last quarter?
ATGGF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Actinogen Medical Limited revenue for the last year?
Actinogen Medical Limited revenue for the last year amounts to 0 USD.
What is Actinogen Medical Limited net income for the last year?
ATGGF net income for the last year is -19.06M USD.
How many employees does Actinogen Medical Limited have?
As of June 20, 2026, the company has 6 employees.
In which sector is Actinogen Medical Limited located?
Actinogen Medical Limited operates in the Health & Wellness sector.
When did Actinogen Medical Limited complete a stock split?
The last stock split for Actinogen Medical Limited was on December 06, 2017 with a ratio of 17:15.
Where is Actinogen Medical Limited headquartered?
Actinogen Medical Limited is headquartered in Sydney, United States.